$HLSQ Cashflow Statement | Understand Stock

$HLSQ

$0.21 -$0.05 (18.2%) Close

$HLSQ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS – OPERATING ACTIVITIES
Net loss
Depreciation and amortization
Adjustments required to reconcile net loss to cash flows used in operating activities
Depreciation
Stock-based compensation
Amortization of debt issuance costs
Finance expense, net
Changes in other liabilities
Loss from sale of property and equipment
Capital loss, net
Gain from early lease termination
Finance expense (income), net
Revaluation of contingent consideration
Income from change in fair value of warrants
Private Placement Warrants issuance cost
Changes in contract liability
Loss from sale and disposal of fixed assets, net
Goodwill impairment
IPR&D impairment
Long-lived assets impairment
Other long-lived asset impairment

Changes in operating assets and liabilities:
Other current assets
Trade account payables
Contract liability
Other account payables
Net change in operating leases

Net cash used in operating activities
CASH FLOWS – INVESTING ACTIVITIES
Proceeds from short -term deposits
Investment in short-term deposits
Cash and restricted cash acquired from the APT acquisition
Proceeds from short-term deposits
Purchase of property and equipment
Proceeds from sale of property and equipment
Net cash provided by investing activities

CASH FLOWS – FINANCING ACTIVITIES
Issuance of Common Stock and warrants under PIPE
Proceeds from long-term debt, net of issuance costs
Exercise of stock options
Issuance of Common Stock under February 2025 SPA
Issuance of Common Stock under registered direct offering, net of issuance costs
Issuance costs from February 2023 PIPE
February 2025 SPA issuance costs
Issuance of Common Warrants under February 2025 SPA
Issuance of Common Stock under Inducement Letter Agreements
Pre-Funded Warrants exercise
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs
Repayment of long-term debt
Issuance of Private Placement Warrants under March 2024 PIPE
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE
March 2024 PIPE issuance costs
Net cash provided by financing activities

Increase (decrease) in cash and cash equivalents and restricted cash
Effect of exchange rate changes on cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at the beginning of the year
Cash and cash equivalents and restricted cash at the end of the year
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest
Taxes paid in Israel
Property and equipment purchases included in accounts payable and other payables
Right-of-use assets obtained in exchange for new operation lease liabilities

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:
Lease liability and Operating lease right-of-use asset remeasurement
Derecognition of right-of-use asset as a result of operating lease termination
Derecognition of lease liability as a result of operating lease termination
Property and equipment purchases included in accounts payable
Issuance cost from March 2024 PIPE
Issuance of Common Stock under the APT acquisition
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition
Issuance of Merger Warrants under the APT acquisition
Redeemable Convertible Preferred Shares conversion into shares of Common Stock
Cash and cash equivalents
Restricted cash

Comments